Culver City, CA, Nov. 12, 2019 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation – (EWLL) – a provider of the state of the art PHZIO platform for the physical therapy (“PT”) and telehealth markets, announced today that it is developing a new Rheumatoid Arthritis Treatment Platform called RA360. The new platform is anticipated to be available in Q-1, 2020. Rheumatoid Arthritis and related autoimmune disorders are the leading cause of illness and disability in the US.
One in four Americans have arthritis or one of its 100 related autoimmune disorders in 2019. Rheumatoid Arthritis (RA): Those with Rheumatoid arthritis will need to go on disability or stop work entirely within 2 years of onset. Our innovative RA360 solution is anticipated to support employees to reduce or maintain their current level of theraputic drug use.
Total costs associated with arthritis and its related conditions hit $128 billion in 2005, other studies estimated that the cost was actually much closer to $353 billion when payouts, lost wages and other associated medical costs were accounted for. Reduction in RA symptoms will alleviate stress on the health care system and the employer. Arthritis isn’t an individual problem, it’s everyone’s problem. The damage cannot be undone but can be managed. EWLL is part of this solution.
eWellness Healthcare Corporation (EWLL) is the first physical therapy telehealth company to offer real-time distance monitored assessments and treatments. Our business model is to have large-scale employers use our MSK 360 and or PHZIO platform as a fully PT monitored corporate MSK wellness program. The Company’s MSK 360 and PHZIO home physical therapy assessment and exercise platform has been designed to disrupt the $30 billion physical therapy market, the $4 billion MSK market and the $8 billion corporate wellness industry. PHZIO re-defines the way MSK physical therapy can be delivered. PHZIO is the first real-time remote monitored 1-to-many MSK physical therapy platform for home use.
For more information on eWellness go to:
Safe Harbor Statement
This news release includes certain information that may constitute forward-looking statements. Forward-looking statements are typically identified by terminology such as “could,” “may,” “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “proposed,” “planned,” “potential” and similar expressions, or are those, which, by their nature, refer to future events. All statements, other than statements of historical fact, included herein, including statements about eWellness’ beliefs and expectations, are forward-looking statements. Forward-looking information is necessarily based upon a number of assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Although eWellness believes that such statements are reasonable, it can give no assurance that such forward-looking information will prove to be accurate. eWellness cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors. Accordingly, due to the risks, uncertainties and assumptions inherent in forward-looking information, readers and prospective investors in the Company’s securities should not place undue reliance on forward-looking information. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof and is subject to change. The Company assumes no obligation to revise or update forward-looking information to reflect new circumstances, whether as a result of new information, future events or otherwise, except as required by law.
For additional information on eWellness Healthcare Corporation and its PHZIO telehealth products please contact Mr. Darwin Fogt, CEO: 1-855-470-1700